HIVE vs PWP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 27, 2026

HIVE

37.0
AI Score
VS
PWP Wins

PWP

64.6
AI Score

Investment Advisor Scores

HIVE

37score
Recommendation
AVOID NEW MONEY

PWP

65score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HIVE PWP Winner
Forward P/E 62.8931 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 73.5% 0.8% HIVE
Earnings Growth -99.9% 52.2% PWP
Tradestie Score 37.0/100 64.6/100 PWP
Profit Margin -98.5% 3.2% PWP
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD PWP

Relative Price Performance (Last 90 Days)

HIVE 1M: +7.2% · 3M: -13.8% PWP 1M: -2.6% · 3M: -7.3%

Current Technical Phase

HIVE

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.7%) with fading momentum, RSI 44

RSI (14): 44.2 · Price: $2.92

PWP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 56.9 · Price: $15.96

Fundamentals Snapshot

Metric HIVE PWP
Market Cap — —
Forward P/E -5.7 10.8
Trailing P/E — 62.7
Revenue (TTM) — —
Revenue Growth 0.7% 0.0%
Gross Margin 0.4% 1.0%
Operating Margin -0.6% 0.1%
EPS -1.39 0.26
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, PWP is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.